Stay updated on Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Sign up to get notified when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The page’s footer release/version label was updated from Revision v3.5.2 to Revision v3.5.3, indicating a minor platform update rather than a change to the trial information.
    Difference
    0.0%
    Check dated 2026-04-25T18:55:26.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated: added v3.5.2 and removed v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-18T14:02:34.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    Revision metadata updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T01:16:23.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.2 to v3.4.3 on the page. The old revision tag v3.4.2 was removed and the new v3.4.3 tag added to reflect an update.
    Difference
    0.0%
    Check dated 2026-03-06T17:50:35.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2. No study data or user-facing content is affected.
    Difference
    0.0%
    Check dated 2026-02-13T07:55:07.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.1 and no longer displays Revision: v3.4.0.
    Difference
    0.0%
    Check dated 2026-02-05T14:36:37.000Z thumbnail image

Stay in the know with updates to Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Abrocitinib vs Dupilumab in Adult Atopic Dermatitis Clinical Trial page.